Tessenderlo Group NV (TESB) | Financial Analysis & Statements
Tessenderlo Group NV | Large-cap | Basic Materials
Tessenderlo Group NV | Large-cap | Basic Materials
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
2.6B
Gross Profit
513.1M
19.38%
Operating Income
58.7M
2.22%
Net Income
44.0M
1.66%
EPS (Diluted)
€0.70
Balance Sheet Metrics
Total Assets
2.9B
Total Liabilities
1.0B
Shareholders Equity
1.9B
Debt to Equity
0.53
Cash Flow Metrics
Operating Cash Flow
93.3M
Free Cash Flow
152.6M
Revenue & Profitability Trend
Tessenderlo Group NV Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.6B | 2.9B | 2.6B | 2.1B | 1.7B |
| Cost of Goods Sold | 2.1B | 2.4B | 1.9B | 1.5B | 1.3B |
| Gross Profit | 513.1M | 558.2M | 668.0M | 547.0M | 481.5M |
| Operating Expenses | 458.5M | 440.2M | 354.1M | 318.4M | 300.5M |
| Operating Income | 58.7M | 119.5M | 313.7M | 227.3M | 179.5M |
| Pre-tax Income | 46.6M | 116.4M | 289.2M | 230.9M | 133.6M |
| Income Tax | 2.6M | 2.0M | 62.4M | 42.6M | 34.9M |
| Net Income | 44.0M | 114.4M | 226.8M | 188.3M | 98.6M |
| EPS (Diluted) | €0.70 | €1.74 | €5.26 | €4.36 | €2.30 |
Income Statement Trend
Tessenderlo Group NV Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.3B | 1.3B | 1.2B | 1.1B | 860.7M |
| Non-Current Assets | 1.7B | 1.7B | 1.1B | 1.1B | 1.1B |
| Total Assets | 2.9B | 2.9B | 2.3B | 2.2B | 2.0B |
| Liabilities | |||||
| Current Liabilities | 599.7M | 490.2M | 453.5M | 597.9M | 361.8M |
| Non-Current Liabilities | 422.7M | 475.7M | 444.1M | 477.8M | 700.5M |
| Total Liabilities | 1.0B | 965.9M | 897.6M | 1.1B | 1.1B |
| Equity | |||||
| Total Shareholders Equity | 1.9B | 1.9B | 1.4B | 1.1B | 904.1M |
Balance Sheet Composition
Tessenderlo Group NV Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 44.0M | 114.4M | 226.8M | 188.3M | 98.6M |
| Operating Cash Flow | 93.3M | 205.5M | 29.9M | 40.9M | 103.8M |
| Investing Activities | |||||
| Capital Expenditures | -178.5M | -176.9M | -111.2M | -88.7M | -93.7M |
| Investing Cash Flow | -232.0M | -76.1M | -193.4M | -78.7M | -121.5M |
| Financing Activities | |||||
| Dividends Paid | -54.0M | -39.9M | - | - | - |
| Financing Cash Flow | -61.8M | -88.4M | -135.6M | -42.8M | -43.2M |
| Free Cash Flow | 152.6M | 40.7M | 86.4M | 152.1M | 182.1M |
Cash Flow Trend
Tessenderlo Group NV Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
35.71
Forward P/E
13.74
Price to Book
0.80
Price to Sales
0.57
PEG Ratio
13.74
Profitability Ratios
Profit Margin
1.62%
Operating Margin
-0.91%
Return on Equity
2.28%
Return on Assets
0.96%
Financial Health
Current Ratio
2.11
Debt to Equity
13.46
Beta
0.49
Per Share Data
EPS (TTM)
€0.70
Book Value per Share
€31.35
Revenue per Share
€43.07
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| tesb | 1.5B | 35.71 | 0.80 | 2.28% | 1.62% | 13.46 |
| Biotalys N.V | 166.7M | - | 6.04 | -49.60% | 0.00% | 17.56 |
| Anheuser-Busch InBev | 120.4B | 21.06 | 1.57 | 6.60% | 11.75% | 81.53 |
| Syneos Health | 6.9B | 377.86 | 1.03 | -1.38% | -1.59% | 28.51 |
| Azelis Group NV | 3.2B | 17.86 | 1.12 | 6.77% | 4.29% | 63.15 |
| Solvay SA | 3.1B | 15.83 | 2.26 | 14.16% | 3.88% | 155.68 |
Financial data is updated regularly. All figures are in the company's reporting currency.